Found: 2

Select item for more details and to access through your institution.

  • How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.

    Published in:
    Rheumatology International, 2019, v. 39, n. 2, p. 395, doi. 10.1007/s00296-018-4205-z
    By:
    • RENACER Study Group (REgistro NAcional CERtolizumab);
    • Torrente-Segarra, Vicenç;
    • Fernandez Prada, Manuel;
    • Expósito Moliner, Rosa;
    • Garrido Puñal, Noemí Patricia;
    • Sánchez-Andrade Fernández, Amalia;
    • Lamua Riazuelo, José Ramón;
    • Olivé, Alejandro;
    • Tovar Beltrán, Juan Víctor
    Publication type:
    Article

  • RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database.

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 3, p. 336, doi. 10.3109/14397595.2015.1101200
    By:
    • Torrente-Segarra, Vicenç;
    • Arana, Ana Urruticoechea;
    • Fernández, Amalia Sánchez-Andrade;
    • Tovar Beltrán, Juan Víctor;
    • Muñoz Jiménez, Alejandro;
    • Martínez-Cristóbal, Anna;
    • González Ferrández, José Antonio;
    • Fernández Prada, Manuel;
    • Vázquez Fuentes, Noelia;
    • Corominas, Hèctor;
    • García-Díaz, Sílvia;
    • Acosta Pereira, Asunción;
    • Ruiz Martín, José Miguel;
    • Lamua Riazuelo, José Ramón;
    • Expósito Moliner, Rosa;
    • Ruiz Vilchez, Desireé;
    • Veiga Cabello, Raúl;
    • Carlos Fernández, Jesús;
    • Noguera Pons, José Raúl;
    • Garrido Puñal, Noemí Patricia
    Publication type:
    Article